Education
About Us
Working with TipRanks
Follow Us
Bill Larkins Insider Profile
4 Followers
Bill Larkins, Divisional President at Hikma Pharmaceuticals, holds ― shares in Hikma Pharmaceuticals (Ticker: GB:HIK). Most recently, Bill Larkins Sold 5,257p shares of Hikma Pharmaceuticals on Jun 05, 2025 for an estimated value of 111.87K.
Bill Larkins Hikma Pharmaceuticals (HIK)Divisional President
Hikma Pharmaceuticals (HIK)
Divisional President
Ranked #51,454 out of 102,123 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-0.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Bill Larkins does not currently own shares as a corporate insider.
A breakdown of Bill Larkins's holdings
Insider Roles
Divisional President
Roles that Bill Larkins holds in companies
Most Profitable Insider Trade
The most profitable trade made by Bill Larkins
Bill Larkins's Trading History
List of latest transactions for each holding click on a transaction to see Bill Larkins's performance on stock
You May Also Like
Bill Larkins insider profile FAQ
What is the percentage of profitable transactions made by Bill Larkins?
The percentage of profitable transactions made by Bill Larkins is 0%.
What is the average return per transaction made by Bill Larkins?
The average return per transaction made by Bill Larkins is -0.50%.
What stocks does Bill Larkins hold?
Bill Larkins holds: GB:HIK stocks.
What was Bill Larkins’s latest transaction?
Bill Larkins latest transaction was an Informative Sell of 111.87K.
What was Bill Larkins's most profitable transaction?
Bill Larkins’s most profitable transaction was an Informative Sell of GB:HIK stock on June 3, 2025. The return on the trade was 0.00%.
What is Bill Larkins's role in Hikma Pharmaceuticals?
Bill Larkins's role in Hikma Pharmaceuticals is Divisional President.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.